Sarepta Therapeutics (SRPT) PT Raised to $96 at Nomura/Instinet on 4Q Beat; 'Pipeline Registration Path & DMD Gene Therapies Emerge in 2018'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. APGE
6. LLY
7. DFTX
8. RGNX
9. GOOGL
10. LCO

Go back to Sarepta Therapeutics (SRPT) PT Raised to $96 at Nomura/Instinet on 4Q Beat; 'Pipeline Registration Path & DMD Gene Therapies Emerge in 2018'
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.64 +0.11 (0.63%)
Previous Close $17.53    52 Week High $63.73 
Open $17.82    52 Week Low $8.00 
Day High $18.00    P/E N/A 
Day Low $17.50    EPS $-5.69 
Volume 377,594